Photobiomodulation (low-level light therapy) and dry eye disease

Area of Science:

• Ophthalmology
• Biomedical Engineering

Background:

• Dry eye disease affects up to 50% of patients in clinical settings.
• Evaporative dry eye, often due to meibomian gland dysfunction (MGD), is a primary cause.
• Current MGD treatments include warm compresses, eyelid hygiene, gland expression, and artificial tears.

Purpose of the Study:

• To review the efficacy and safety of low-level light therapy (LLLT), also known as photobiomodulation, for MGD and dry eye disease.
• To explore the proposed mechanisms of action for LLLT in treating MGD.

Main Methods:

• Literature review of studies on photobiomodulation for MGD and dry eye.
• Analysis of research investigating the effects of red or near-infrared radiation on ocular tissues.

Main Results:

• Photobiomodulation is a recent in-office treatment for MGD.
• LLLT is suggested to promote tissue repair, reduce inflammation, and alleviate pain.
• The review assesses the available evidence on LLLT's efficacy and safety.

Conclusions:

• LLLT presents a novel therapeutic option for MGD and associated dry eye disease.
• Further research is needed to fully understand LLLT's mechanism and optimize its clinical application.